Mechanism and Potential Treatment of Guillain Barr Syndrome and Related Neuropathy
Abstract
Guillain-Barre Syndrome (GBS) encompasses a group of polyneuropathies of high medical importance that affect mainly the peripheralnervous system (PNS). In the current model of GBS an adaptive immune response to microbial infection is cross-reactive and destructive to theglycosphingolipids in the protective myelin sheath surrounding axons in the PNS. Damage to myelin results in a several types of clinical manifestation. Recovery usually takes place over the course of several months but a significant number of patients have persistent longer term or permanent neural damage. In our nonhuman primate model of GBS spectrum disease triggered by virusinfection we find multiple hallmarks of neural inflammatory disease, damage to the blood-brain barrier, and upregulation of a key cytokine likely important in the induction of neural damage.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2021
- Accession Number
- AD1133880
Entities
People
- Antonito T Panganiban
Organizations
- Tulane National Primate Research Center